...exclusive, worldwide rights outside of China to TDI01, a targeted inhibitor of ROCK2. Tide, a Sino Biopharmaceutical Ltd....
...containing protein kinase 2 BC Staff NeuroRx Inc. BGI Genomics Co. Ltd. Clover Biopharmaceuticals Day One Biopharmaceuticals LLC Merck KGaA Teon Therapeutics Inc. Sino Biopharmaceutical Ltd. Asalyxa...

...hospital marketGenetron Holdings Ltd. (NASDAQ:GTH) partnered with Sino Biopharmaceutical Ltd....
...Staff Ribometrix Genentech Pfizer Dewpoint Therapeutics Kite Pharma Gilead Oxford BioTherapeutics Illumina Fate Therapeutics Y-Biologics 3D Medicines Corp. Genetron Health Sino Biopharmaceutical...

...2020 deal partners include Astellas Pharma Inc. (Tokyo:4503), Boehringer Ingelheim GmbH, Pfizer Inc. (NYSE:PFE) and Sino Biopharmaceutical Ltd....

...93% to 97% in patients with skin lesions. Beijing Tide, Insilico partner for cancer therapies Sino Biopharmaceutical Ltd....

...Six months after establishing a joint venture with Akeso, Sino Biopharmaceutical has co-led a series D round...
...targeting PD-1. In June, the Chia Tai Tianqing Pharmaceutical Group Co. Ltd. (CTTQ) subsidiary of Sino Biopharmaceutical Ltd....

...gains, the company ended the day with a market cap of HK$7.8 billion. Cornerstone investor Sino Biopharmaceutical Ltd....

...to develop PD-1 mAb The Chia Tai Tianqing Pharmaceutical Group Co. Ltd. (CTTQ) subsidiary of Sino Biopharmaceutical Ltd....
...Co. Ltd. Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator Jiangsu Hengrui Medicine Co. Ltd. Kowa Co. Ltd. Merck & Co. Inc. Sino Biopharmaceutical Ltd. TrakCel...

...drug Bydureon exenatide and cancer drug pyrotinib from Hengrui could be included, and added that Sino Biopharmaceutical Ltd....
...HK$0.32 to HK$13.32. Hongjiang Li, Staff Writer 3SBio Inc. CSPC Pharmaceutical Group Ltd. Innovent Biologics Inc. Jiangsu Hengrui Medicine Co. Ltd. Sino Biopharmaceutical Ltd. China's...

...have passed equivalence testing. Several tender winners saw gains on Friday following the program’s approval. Sino Biopharmaceutical Ltd....
...and Shenzhen Salubris Pharmaceuticals Co. Ltd. (SZSE:002294) added RMB0.45 to RMB21.20. Hongjiang Li Shenzhen Salubris Pharmaceuticals Co. Ltd. Sino Biopharmaceutical Ltd. Zhejiang...